Access China Management Consulting Ltd is involved in the delivery of management and consulting services. It supplies foreign clients interested in entering China’s market with insightful reviews of different local industry sectors. Access China also describes business climate in the country, including laws, administrative regulations, trade and investment certification, licensing, and a far more.
Access China provides research studies covering three major areas: strategic investment, market research and international trade. The company’s experienced specialist team gathers important and precise data on the Chinese market to grant its customers access to the most successful, prime-quality and cost saving business solutions.
The company’s research reports help to develop effective market-entry strategies and, thereby, take the lead over other competitors. Access China Management Consulting offers the most reliable information, thus assisting its clients in creating business/market strategies and enforcing the decision-making process.
Publications found:
36
Sort by:
Latest guidebook for Chinese Medical Device Recall Regulations (2019 Edition)
US$ 750.00
... knowledge of the Chinese latest regulations on medical device recall. Latest guidebook for Chinese Medical Device Recall Regulations (2019 Edition) is an essential resource for overseas and multinational medical device manufacturers to handle a medical device recall smoothly in China, which provides not ...
January 2019
44 pages
Latest Guidebook for Chinese In-Vitro Diagnostic Reagent GMP Regulations
US$ 750.00
... site Inspection Guideline of Good Manufacturing Practice (GMP) for Medical Devices, On-site Inspection Guideline for In-vitro Diagnosis Reagent GMP Implementation Regulations respectively. Everything changed. Facing sharp changes of in-vitro diagnostic reagent GMP regulations ...
November 2015
134 pages
Latest Guidebook for Chinese Medical Device GMP Regulations
US$ 1,495.00
... Chinese Good Manufacturing Practice (GMP) Regulations for Medical Devices, as well as the latest On-site Inspection Guideline of Good Manufacturing Practice (GMP) for Medical Devices, On-site Inspection Guideline for Sterile Medical Device GMP Implementation Regulations, and On-site Inspection Guideline ...
October 2015
217 pages
Latest Chinese Guidance for Development, Evaluation, License Approval of Biosimilars
US$ 750.00
... latest Chinese guidance for development, evaluation, license approval of biosimilars, Latest Chinese Guidance for Development, Evaluation, License Approval of Biosimilars provided a comprehensive and thorough knowledge of the latest Chinese guidance for development, evaluation, license approval of biosimilars ...
May 2015
48 pages
Chinese guidebook for Adverse Drug Reaction Reporting and Monitoring Regulations (2014)
US$ 750.00
... Chinese regulations for adverse drug reaction reporting and monitoring. The regulations on adverse drug reaction reporting and monitoring between China ... to clearly understand submitted forms for adverse drug reaction and event reporting. The audiences of this guidebook are overseas pharmaceutical companies ...
March 2014
50 pages
Latest Guide to Chinese Pharmaceutical GMP Regulations
US$ 750.00
China possesses a fourth population in the world and has one of the largest drug markets round the world. By 2011, sales on the Chinese drug market have reached RMB 1550 billion (about US$246 billion)...
July 2012
135 pages
Guidebook Series for Investing in China (Second Edition)
US$ 4,800.00
Special Discounts: For single user licence: Buy two fascicles for USD 3200 (20% discount);Buy three fascicles for USD 4200 (30% discount);Buy all four fascicles for USD 4800 (40% discount); For site...
April 2012
1591 pages
China’s Guidebook for Pharmaceutical Patent Protection
US$ 1,495.00
Description China possesses a fourth population in the world and has one of the largest drug markets round the world. By 2011, sales on the Chinese drug market have reached RMB 1550 billion (about US...
February 2012
230 pages
A Guide to Mergers and Acquisitions in China
US$ 200.00
Alongside the establishment of the State-owned Asset Supervision and Administration Commission (SASAC) of the State Council in March 2003, Chinese authorities start to orderly construct a new state-ow...
May 2011
82 pages